0.3903
price up icon0.85%   0.0033
after-market Dopo l'orario di chiusura: .39 -0.0003 -0.08%
loading

Athira Pharma Inc Azioni (ATHA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
14.90%
3.661
4.302 17.92 22.15 21.24
Costs And Expenses
23.54%
7.291
9.536 29.62 28.03 27.69
Operating Income/Loss
23.54%
-7.291
-9.536 -29.62 -28.03 -27.69
Income/Loss From Continuing Operations Before Tax
20.26%
-7.291
-9.143 -29.62 -26.86 -26.34
Income/Loss From Continuing Operations After Tax
23.81%
-6.966
-9.143 -28.74 -26.86 -26.34
Net Income/Loss
23.81%
-6.966
-9.143 -28.74 -26.86 -26.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.13%
39.09
39.04 38.52 38.38 38.32
Diluted Average Shares
0.13%
39.09
39.04 38.52 38.38 38.32
Basic Earnings Per Share
21.74%
-0.18
-0.23 -0.75 -0.70 -0.69
Diluted Earnings Per Share
21.74%
-0.18
-0.23 -0.75 -0.70 -0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):